There were 741 press releases posted in the last 24 hours and 440,991 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Adamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in Epilepsy

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image